Skip to main content

Cerebellar white-matter changes in cannabis users with and without schizophrenia

Journal Article


Download full-text (Open Access)

Abstract


  • Background. The cerebellum is rich in cannabinoid receptors and implicated in the neuropathology of schizophrenia.

    Long-term cannabis use is associated with functional and structural brain changes similar to those evident in schizophrenia,

    yet its impact on cerebellar structure has not been determined. We examined cerebellar grey and white

    matter in cannabis users with and without schizophrenia.

    Method. Seventeen patients with schizophrenia and 31 healthy controls were recruited ; 48% of the healthy group

    and 47% of the patients were long-term heavy cannabis users (mean 19.7 and 17.9 years near daily use respectively).

    Cerebellar measures were extracted from structural 3-T magnetic resonance imaging (MRI) scans using semiautomated

    methods, and examined using analysis of covariance (ANCOVA) and correlational analyses.

    Results. Cerebellar white-matter volume was reduced in cannabis users with and without schizophrenia compared

    to healthy non-users, by 29.7% and 23.9% respectively, and by 17.7% in patients without cannabis use. Healthy

    cannabis users did not differ in white-matter volume from either of the schizophrenia groups. There were no group

    differences in cerebellar grey matter or total volumes. Total cerebellar volume decreased as a function of duration of

    cannabis use in the healthy users. Psychotic symptoms and illness duration correlated with cerebellar measures

    differentially between patients with and without cannabis use.

    Conclusions. Long-term heavy cannabis use in healthy individuals is associated with smaller cerebellar white-matter

    volume similar to that observed in schizophrenia. Reduced volumes were even more pronounced in patients with

    schizophrenia who use cannabis. Cannabis use may alter the course of brain maturational processes associated with

    schizophrenia.

UOW Authors


  •   Solowij, Nadia
  •   Yucel, Murat (external author)
  •   Respondek, Colleen M.
  •   Whittle, Sarah (external author)
  •   Lindsay, Evelyn (external author)
  •   Pantelis, Christos (external author)
  •   Lubman, Daniel I. (external author)

Publication Date


  • 2011

Citation


  • Solowij, N., Yucel, M., Respondek, C., Whittle, S., Lindsay, E., Pantelis, C. & Lubman, D. I. (2011). Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychological Medicine, 41 (11), 2349-2359.

Scopus Eid


  • 2-s2.0-80054916654

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=2174&context=hbspapers

Ro Metadata Url


  • http://ro.uow.edu.au/hbspapers/1125

Has Global Citation Frequency


Number Of Pages


  • 10

Start Page


  • 2349

End Page


  • 2359

Volume


  • 41

Issue


  • 11

Abstract


  • Background. The cerebellum is rich in cannabinoid receptors and implicated in the neuropathology of schizophrenia.

    Long-term cannabis use is associated with functional and structural brain changes similar to those evident in schizophrenia,

    yet its impact on cerebellar structure has not been determined. We examined cerebellar grey and white

    matter in cannabis users with and without schizophrenia.

    Method. Seventeen patients with schizophrenia and 31 healthy controls were recruited ; 48% of the healthy group

    and 47% of the patients were long-term heavy cannabis users (mean 19.7 and 17.9 years near daily use respectively).

    Cerebellar measures were extracted from structural 3-T magnetic resonance imaging (MRI) scans using semiautomated

    methods, and examined using analysis of covariance (ANCOVA) and correlational analyses.

    Results. Cerebellar white-matter volume was reduced in cannabis users with and without schizophrenia compared

    to healthy non-users, by 29.7% and 23.9% respectively, and by 17.7% in patients without cannabis use. Healthy

    cannabis users did not differ in white-matter volume from either of the schizophrenia groups. There were no group

    differences in cerebellar grey matter or total volumes. Total cerebellar volume decreased as a function of duration of

    cannabis use in the healthy users. Psychotic symptoms and illness duration correlated with cerebellar measures

    differentially between patients with and without cannabis use.

    Conclusions. Long-term heavy cannabis use in healthy individuals is associated with smaller cerebellar white-matter

    volume similar to that observed in schizophrenia. Reduced volumes were even more pronounced in patients with

    schizophrenia who use cannabis. Cannabis use may alter the course of brain maturational processes associated with

    schizophrenia.

UOW Authors


  •   Solowij, Nadia
  •   Yucel, Murat (external author)
  •   Respondek, Colleen M.
  •   Whittle, Sarah (external author)
  •   Lindsay, Evelyn (external author)
  •   Pantelis, Christos (external author)
  •   Lubman, Daniel I. (external author)

Publication Date


  • 2011

Citation


  • Solowij, N., Yucel, M., Respondek, C., Whittle, S., Lindsay, E., Pantelis, C. & Lubman, D. I. (2011). Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychological Medicine, 41 (11), 2349-2359.

Scopus Eid


  • 2-s2.0-80054916654

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=2174&context=hbspapers

Ro Metadata Url


  • http://ro.uow.edu.au/hbspapers/1125

Has Global Citation Frequency


Number Of Pages


  • 10

Start Page


  • 2349

End Page


  • 2359

Volume


  • 41

Issue


  • 11